Common Contracts
2 similar Investor Rights Agreement contracts by Protagonist Therapeutics, Inc
EX-4.2 7 d144462dex42.htm EX-4.2 PROTAGONIST THERAPEUTICS, INC. THIRD AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT July 31, 2016 PROTAGONIST THERAPEUTICS, INC. THIRD AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENTInvestor Rights Agreement • May 5th, 2020 • Delaware
PROTAGONIST THERAPEUTICS, INC. THIRD AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT July 31, 2016Investor Rights Agreement • August 1st, 2016 • Protagonist Therapeutics, Inc • Pharmaceutical preparations • Delaware
This Third Amended and Restated Investor Rights Agreement (the “Agreement”) is entered into as of this 31st day of July 2016, by and among Protagonist Therapeutics, Inc., a Delaware corporation (the “Company”) and the holders of the Preferred Stock listed on Exhibit A attached hereto (referred to herein as the “Preferred Holders” or the “Investors”).
